NanoRepro AG
NN6 | F
Overview
Corporate Details
- ISIN(s):
- DE0006577109
- LEI:
- 3912008FCA63AGIMEV74
- Country:
- Germany
- Address:
- UNTERGASSE 8, 35037 MARBURG
- Website:
- https://www.nanorepro.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
NanoRepro AG, based in Marburg an der Lahn, specializes in the development, manufacture and national and international distribution of medical self-tests and is primarily active in health planning and prevention. The company addresses a rapidly growing market, which is characterized by the steadily increasing health awareness of the population and will continue to gain in importance in the coming years. NanoRepro has 24 rapid tests in its portfolio and is continuously expanding it. Among others, the company has already established 2 pregnancy tests, a test for male fertility determination, a test for gastric health as well as a range of different allergy tests and tests for preventive health care on the market.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for NanoRepro AG.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-05 14:00 |
Director's Dealing
NanoRepro AG: Lisa Jungst, buy
|
German | 6.0 KB | |
| 2025-07-21 00:00 |
Annual / Quarterly Financial Statement
Berichtigung der Veröffentlichung vom 14.03.2025
|
German | 15.0 KB | |
| 2025-07-18 15:00 |
Earnings Release
NanoRepro AG: Endgultige Jahreszahlen 2024 - NanoRepro bleibt auf Wachstumskurs
|
German | 14.4 KB | |
| 2025-05-26 14:01 |
Director's Dealing
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 6.0 KB | |
| 2025-05-19 12:01 |
Director's Dealing
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 6.0 KB | |
| 2025-05-08 15:01 |
Director's Dealing
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 5.9 KB | |
| 2025-04-29 14:00 |
M&A Activity
NanoRepro AG: NanoRepro AG investiert in Kaltplasma-Technologie und baut ihre M…
|
German | 11.4 KB | |
| 2025-04-16 14:00 |
Regulatory News Service
NanoRepro AG: NanoRepro erhalt EU-Qualitatsmanagementbescheinigung nach Verordn…
|
German | 8.9 KB | |
| 2025-03-27 15:46 |
Director's Dealing
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 5.9 KB | |
| 2025-03-26 16:01 |
Director's Dealing
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 5.9 KB | |
| 2025-03-14 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 34.7 KB | |
| 2025-02-26 09:45 |
Director's Dealing
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 6.0 KB | |
| 2025-02-25 09:45 |
Director's Dealing
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 6.0 KB | |
| 2025-02-18 12:20 |
Director's Dealing
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 6.0 KB | |
| 2025-02-17 12:20 |
Director's Dealing
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 6.0 KB |
Automate Your Workflow. Get a real-time feed of all NanoRepro AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for NanoRepro AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-25 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 14,506.24 EUR |
| 2025-02-17 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 18,750.00 EUR |
| 2024-10-29 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 17,300.00 EUR |
| 2024-10-22 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 8,949.96 EUR |
| 2024-10-22 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 8,500.00 EUR |
| 2024-10-21 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 8,750.00 EUR |
| 2024-10-21 | Stiller, Johanna | Close relation | Buy | None | 3,759.00 EUR |
| 2024-08-30 | ASS GmbH | Close relation | Buy | None | 30,644.30 EUR |
| 2024-07-25 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 3,279.18 EUR |
| 2024-07-24 | Jüngst, Lisa | Board | Buy | None | 21,762.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Theraclion SA | France | ALTHE | |
|
Tobii Dynavox | Sweden | TDVOX | |
|
TRISTEL PLC | United Kingdom | TSTL | |
| TruSpine Technologies Plc | United Kingdom | N/A | ||
|
VibroSense Dynamics AB | Sweden | VSD B | |
|
Visiomed Group SA | France | ALVMG | |
|
Vitrolife | Sweden | VITR | |
|
Ypsomed Holding AG | Switzerland | YPSN | |
|
Zenicor Medical Systems AB | Sweden | ZENI | |
|
Zur Rose Group AG | Switzerland | ROSE |